GBS Colonization Rate in Pregnant Women
Approximately 10-30% of pregnant women are colonized with Group B Streptococcus (GBS) in the vagina or rectum 1.
Colonization Prevalence
The CDC guidelines establish the benchmark colonization rate at 10-30% of pregnant women 1. This represents the most authoritative estimate based on comprehensive surveillance data and forms the foundation for universal screening recommendations.
Regional and Methodological Variations
Recent research demonstrates variability in colonization rates depending on:
- Detection method: qPCR identifies colonization in approximately 7.3% of women, while traditional culture methods detect only 3.9% 2, highlighting that detection methodology significantly impacts reported rates
- Geographic location: Studies from specific regions report rates ranging from 21-22% 3, 4, 5
- Population demographics: One recent study reported rates as high as 20-40% 6, though this appears to be an outlier
Important Clinical Context
GBS colonization is dynamic during pregnancy - it can be transient, intermittent, or persistent 1. This means:
- A woman colonized during one pregnancy may not be colonized in subsequent pregnancies
- The gastrointestinal tract serves as the primary reservoir and source of vaginal colonization
- Timing of screening matters because colonization status can change
Risk Implications
Among colonized mothers without intervention, 1-2% of infants will develop early-onset GBS disease 1. Maternal colonization increases the risk of delivering an infant with early-onset disease by more than 25-fold compared to non-colonized women 1.
Common Pitfall to Avoid
Do not assume that older colonization data (>5 weeks before delivery) remains valid - colonization status can change, which is why the CDC recommends screening at 36-37 weeks gestation rather than earlier in pregnancy.